Longitudinal examination of perfusion and angiogenesis markers in primary colorectal tumors shows distinct signatures for metronomic and maximum-tolerated dose strategies.

Despite an overall decline in over the last two decades, it is known that individuals younger than 50 years [2] have shown an increasing trend in incidence, which is likely to hold in the near future.

also in 63,971 other papers